156 related articles for article (PubMed ID: 7250468)
1. [Percutaneous absorption of triamcinolone 16 alpha, 17 alpha cyclopentylene-dioxy-21-acetate (author's transl)].
Meynadier J; Guilhou JJ; Peyron JL
Dermatologica; 1981; 162(5):336-41. PubMed ID: 7250468
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
Taylor KS; Malkinson FD; Gak C
Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
[TBL] [Abstract][Full Text] [Related]
3. [Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)].
Wepierre J; Bogaievsky Y
J Pharmacol; 1980; 11(4):449-62. PubMed ID: 7206733
[TBL] [Abstract][Full Text] [Related]
4. [Pituitary adrenal axis activity during topical treatment with 0,075 g% triamcinolone benetonide cream (author's transl)].
Meynadier J; Guillot B
Dermatologica; 1982 May; 164(5):327-30. PubMed ID: 6284561
[No Abstract] [Full Text] [Related]
5. [Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)].
Täuber VU
Arzneimittelforschung; 1976; 26(7b):1479-84. PubMed ID: 1036943
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous absorption of 14C-9alpha-fluoro-11beta,21-dihydroxy-3,20-dioxopregna-1,4-dieno (17alpha,16alpha-d)-2'-methyloxazolidine-21-acetate (L 6400) in rats, pigs and humans. Comparison with 3H-triamcinolone acetonide.
Lewis JD; Cameron BD; Hawkins DR; Chasseaud LF; Franklin ER
Arzneimittelforschung; 1975 Oct; 25(10):1646-50. PubMed ID: 54172
[TBL] [Abstract][Full Text] [Related]
7. Plasma cortisol studies with 0.05% halometasone cream and ointment in patients with psoriasis.
Tomasini C; Castiglioni G
J Int Med Res; 1983; 11 Suppl 1():38-42. PubMed ID: 6832467
[TBL] [Abstract][Full Text] [Related]
8. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
Scott M; Malmsten LA; Thelin I
Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
[TBL] [Abstract][Full Text] [Related]
9. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
[TBL] [Abstract][Full Text] [Related]
10. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the external use of triamcinolone acetonide under foil occlussive dressings on the plasma cortisol level and on the diurnal rhythm of plasma cortisol].
Hartmann F; Lahmann JJ
Hautarzt; 1977 Apr; 28(4):198-202. PubMed ID: 559653
[TBL] [Abstract][Full Text] [Related]
12. Kinetic study of the percutaneous absorption of 1,2,4-3H-labelled flupamesone.
Rimbau V; Lleonart F
Arzneimittelforschung; 1975 Jul; 25(7):1040-2. PubMed ID: 1174410
[TBL] [Abstract][Full Text] [Related]
13. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
14. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
Wendt H; Reckers R
Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
[TBL] [Abstract][Full Text] [Related]
15. [Transdermal salicylate absorption and behavior of corticosteroid plasma levels during epidermal administration of an antiphlogistic ointment].
Dasch W; Braun E; Nowack H
Arzneimittelforschung; 1983; 33(8):1196-9. PubMed ID: 6685499
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis.
Bickers DR
Cutis; 1984 Aug; 34(2):190-4. PubMed ID: 6383735
[TBL] [Abstract][Full Text] [Related]
17. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous absorption of topically applied triamcinolone in children.
Rasmussen JE
Arch Dermatol; 1978 Aug; 114(8):1165-7. PubMed ID: 677913
[TBL] [Abstract][Full Text] [Related]
19. [The effect of fluocortin butylester on adrenal function in man (author's transl)].
Wendt H
Arzneimittelforschung; 1977; 27(11a):2236-8. PubMed ID: 580036
[TBL] [Abstract][Full Text] [Related]
20. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
Laeijendecker R; Tank B; Dekker SK; Neumann HA
Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
